ProGenis Pharmaceuticals is proud to announce that we have been awarded the 2025 Rio Tinto Emerging Innovation Award at the Western Australia Innovators of the Year Awards.
This prestigious recognition celebrates our pioneering work in RNA-based therapeutics, particularly our Type 2 Diabetes program, which reflects our commitment to developing innovative healthcare solutions with the potential to create meaningful global impact.
The WA Innovators of the Year Awards recognise outstanding achievements across science, technology, and innovation. We are honoured to be recognised alongside other exceptional winners and finalists whose work continues to advance scientific excellence and support economic growth across Western Australia.
We extend our sincere thanks to our dedicated ProGenis team for their hard work and commitment. We also gratefully acknowledge the support and collaboration of our valued partners, including Murdoch University, MTPConnect, Diabetes WA, Perron Institute, and our Consumer Advisory Group.
ProGenis also thanks the Department of Energy and Economic Diversification, Rio Tinto, and all award sponsors for championing innovation and supporting organisations working to shape the future of healthcare and technology.
Learn more about the 2025 winners and their inspiring contributions:
https://lnkd.in/gph5cdJA